Immunomodulatory Nanomedicine for the Treatment of Atherosclerosis.

ABSTRACT: Atherosclerosis is the main underlying cause of cardiovascular diseases (CVDs), which remain the number one contributor to mortality worldwide. Although current therapies can slow down disease progression, no treatment is available that can fully cure or reverse atherosclerosis. Nanomedicine, which is the application of nanotechnology in medicine, is an emerging field in the treatment of many pathologies, including CVDs. It enables the production of drugs that interact with cellular receptors, and allows for controlling cellular processes after entering these cells. Nanomedicine aims to repair, control and monitor biological and physiological systems via nanoparticles (NPs), which have been shown to be efficient drug carriers. In this review we will, after a general introduction, highlight

SUBMITTER: Peters LJF 

PROVIDER: S-EPMC8306310 | biostudies-literature | 2021 Jul

REPOSITORIES: biostudies-literature